Publication | Open Access
Efficacy and safety of LCZ696 (sacubitril-valsartan) according to age: insights from PARADIGM-HF
220
Citations
20
References
2015
Year
LCZ696 was more beneficial than enalapril across the spectrum of age in PARADIGM-HF with a favourable benefit-risk profile in all age groups.
| Year | Citations | |
|---|---|---|
Page 1
Page 1